Rockin Robin SongFlying The Web For News.

Article Tools/Herramientas de artículos

Consumer Daily Reports

A six-month study found fewer breathing interruptions in people taking the medication

By Kristen Dalli of ConsumerAffairs
October 1, 2026
  • An experimental once-daily pill reduced sleep apnea-related breathing interruptions by about 44% in a phase 3 trial.

  • The study included 646 adults who could not tolerate or declined standard PAP therapy.

  • The medication improved several measures of nighttime breathing and oxygen levels, but side effects led some participants to stop treatment.


For people with obstructive sleep apnea (OSA), keeping the airway open during sleep can be a challenge. The condition causes repeated blockages in the upper airway, which can interrupt breathing and reduce oxygen levels during the night.

Continuous positive airway pressure, or CPAP, is a common treatment, but not everyone is able or willing to use it long term. That has researchers looking for other approaches.

One experimental option is AD109, a once-daily pill that combines two medications: aroxybutynin and atomoxetine. The drugs are designed to increase the activity of muscles in the upper airway during sleep, making the airway less likely to collapse.

"In many other chronic diseases, such as cardiovascular disease, asthma, or type 2 diabetes, it would be unthinkable for the majority of diagnosed patients to remain untreated or undertreated, first author Patrick John Strollo, MD, a sleep medicine physician at the University of Pittsburgh Medical Center, said in a news release. Yet that remains the reality in OSA.

"An oral pill that targets the underlying neuromuscular drivers of airway collapse during sleep could help address this gap and broaden the range of effective options for patients who remain untreated today."

How researchers tested the pill

The phase 3 SynAIRgy trial included 646 adults with mild to severe obstructive sleep apnea who had either been unable to use or had refused positive airway pressure therapy.

Researchers randomly assigned participants to receive either AD109 or a placebo, meaning a pill without the active medications. Neither the participants nor researchers knew who received which treatment during the trial.

The study lasted 26 weeks, or about six months, and was conducted at 69 sites in the U.S. and Canada. Participants underwent overnight sleep studies at the beginning of the trial and again during the study.

Researchers measured their apnea-hypopnea index, or AHI, which tracks how often breathing is interrupted during sleep, along with oxygen levels and other measures of sleep and fatigue.

What the study found

After 26 weeks, people taking AD109 had an estimated 44.1% reduction in their AHI, compared with a 17.6% reduction among those taking the placebo. The medication also improved measures of nighttime oxygen problems, including the number of times oxygen levels dropped and the amount of time participants experienced low oxygen.

More than 40% of people taking AD109 moved into a less severe sleep apnea category, according to the study. However, the medication did not produce a statistically significant improvement in the study's measure of fatigue.

The treatment also had side effects. The most commonly reported were dry mouth, nausea, insomnia, and difficulty urinating. About 21% of participants taking AD109 discontinued treatment because of adverse events, compared with about 3% of those taking the placebo.

For consumers, the findings suggest that an oral medication could eventually provide another treatment option for some people with sleep apnea who cannot use PAP therapy. But AD109 is still an investigational treatment, so the study does not mean that people with sleep apnea should replace their current treatment with the medication.



Posted: 2026-10-01 16:28:29

Get Full News Story On Consumer Affairs




More News From This Category
Consumer News: Your Instagram habits may reveal more than your carefully curated highlights
Fri, 20 Nov 2026 17:07:10 +0000
Your Instagram habits may reveal more than your carefully curated highlights

A new study found that Instagram activity could help researchers identify patterns associated with emotional and social loneliness. People who reported feeling lonelier tended to share fewer photos featuring other people and use more past-focused language. Researchers say social media activity could eventually help identify people who need support, but privacy and accuracy remain important concern...


Consumer News: Thanksgiving food safety starts before the first bite. Here's what to know
Fri, 20 Nov 2026 17:07:10 +0000
Thanksgiving food safety starts before the first bite. Here's what to know

Rutgers experts say consumers should check food recalls before shopping for or preparing Thanksgiving dinner. Proper turkey thawing, food temperatures, and leftover storage are important steps in preventing foodborne illness. Holiday guests can also bring potential hazards for children and pets, including medications, cannabis products, and certain foods. Thanksgiving dinner involves plenty of pla...


Consumer News: Most cannabis products are still missing important label information
Fri, 20 Nov 2026 17:07:09 +0000
Most cannabis products are still missing important label information

A new study found that just 14% of cannabis products sampled at Colorado dispensaries included all required label information. Expiration dates and recommended storage instructions were among the most commonly missing details. Researchers say incomplete labels could make it harder for consumers to understand what they're buying and use cannabis products safely. When purchasing cannabis, consumers...


Consumer News: Consumer product safety recall roundup for November 20, 2026
Fri, 20 Nov 2026 17:07:09 +0000
Consumer product safety recall roundup for November 20, 2026

This roundup covers newly announced recalls and safety warnings from the U.S. Consumer Product Safety Commission and the Food and Drug Administration. CPSC says Cipton youth bicycle helmets do not meet key federal safety requirements and may not protect riders in a crash. The helmets fail to meet mandatory impact, stability and certification requirements, creating a serious risk of head injury or...


Consumer News: JPMorgan Chase confirms data breach affecting thousands of customers
Fri, 20 Nov 2026 14:07:11 +0000
JPMorgan Chase confirms data breach affecting thousands of customers

Thousands of JPMorgan Chase customers may have had personal information exposed after hackers targeted outside companies that provide services to the nation's largest bank. The stolen information reportedly includes names, email addresses and some phone numbers, but Chase says there is no evidence that credit card numbers or other highly sensitive financial information were compromised. Chase says...


Related Bing News Results
Consumer Reports' highest-rated nonstick cookware set is under $200
Tue, 17 Nov 2026 09:39:00 GMT
The quality of your cookware can make or break how you operate in your kitchen, so we want you to know which set Consumer Reports thinks is worth your time.
Consumer Reports reveals 2026 best car brands with affordable winners
Wed, 10 Dec 2025 12:17:00 GMT
Foreign brands snagged 9 of top 10 spots on Consumer Reports magazine's 2026 Automotive Brand Report Card. Jeep placed last. Early adopters pay for innovation with reliability issues. The average ...
10 Vehicles Consumer Reports Rates Highly for Ride Comfort
Sat, 07 Nov 2026 09:15:00 GMT
Ride comfort plays an important role when choosing a vehicle, especially for drivers who spend long hours commuting, travel with family, or regularly cover ...
Consumer Reports finds some kids’ vitamins contain up to 5 times the nutrients listed on labels
Wed, 11 Nov 2026 01:31:00 GMT
Consumer Reports tested 21 children’s vitamins and found each had at least one nutrient level that differed from its label—sometimes by as much as 500%. All products were considered safe, with heavy ...
Consumer Reports tests kids vitamins for heavy metals, label accuracy
Sat, 14 Nov 2026 07:02:00 GMT
Approximately 1 in 3 kids under age 19 regularly take a dietary supplement, according to the Centers for Disease Control and Prevention. But do kids’ vitamins actually contain what they say on the ...

Blow Us A Whistle


RobinsPost Print On Demand Refund Policy With Printify
Printify

Related Product Search/Búsqueda de productos relacionados

Amazon Logo